Entering text into the input field will update the search result below

Cleveland BioLabs reports Q4 results

  • Cleveland BioLabs (CBLI): Q4 EPS of -$0.11
  • Revenue of $1M (-21.3% Y/Y)
  • Press Release

Recommended For You

More Trending News

About STAB Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
STAB--
Statera Biopharma, Inc.